Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

294 Views

Poster Session: COVID-19: Treatment

1113 - Clinical and Virologic Outcomes with Early Adintrevimab (ADI) Monoclonal Antibody Therapy in Mild and Moderate COVID-19

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

Kathryn Mahoney, PharmD

Principal Clinical Scientist
Invivyd, Inc.
Waltham, Massachusetts, United States

Co-Author(s)

KN

Kristin Narayan, PhD

Adagio Therapeutics
Waltham, Massachusetts, United States
NB

Natalia Betancourt, MS

Adagio Therapeutics
Waltham, Massachusetts, United States
YL

Yong Li, PhD

Adagio Therapeutics
Waltham, Massachusetts, United States
DG

Deepali Gupta, B.Sc

Adagio Therapeutics
Waltham, Massachusetts, United States
PH

Pamela Hawn, PharmD

Adagio Therapeutics
Waltham, Massachusetts, United States
PS

Pete Schmidt, MD

VP Clinical Research
Adagio Therapeutics
Waltham, Massachusetts, United States
MP

Myra Popejoy, PharmD

Adagio Therapeutics
Waltham, Massachusetts, United States